Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Operable Breast Neoplasms”

199 trials

Showing 20 of 199 results

Large-scale testing (Phase 3)Looking for participantsNCT05862064
What this trial is testing

A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 606
Not applicableActive Not RecruitingNCT04897009
What this trial is testing

Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer

Who this might be right for
Invasive Breast Carcinoma
Mayo Clinic 38
Not applicableStudy completedNCT02050620
What this trial is testing

Self-Reported Exercise Behavior and Short-Term Patient Outcomes in Women Undergoing Radiation Treatment for Operable Breast Cancer

Who this might be right for
Breast Cancer
Duke University 45
Testing effectiveness (Phase 2)Study completedNCT00422903
What this trial is testing

Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 92
Early research (Phase 1)Study completedNCT00882674
What this trial is testing

Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 8
Large-scale testing (Phase 3)Study completedNCT00021255
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer

Who this might be right for
Breast Neoplasms
Sanofi 3,222
Testing effectiveness (Phase 2)UnknownNCT00005821
What this trial is testing

Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust
Testing effectiveness (Phase 2)Study completedNCT00629616
What this trial is testing

Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer

Who this might be right for
Breast Cancer
UNICANCER 116
Testing effectiveness (Phase 2)Study completedNCT03272477
What this trial is testing

Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients

Who this might be right for
Breast Neoplasms
Palleos Healthcare GmbH 257
Large-scale testing (Phase 3)Study completedNCT00017095
What this trial is testing

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,856
Early research (Phase 1)Study completedNCT01133912
What this trial is testing

Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb®) (PGT)

Who this might be right for
Breast Cancer
Jungsil Ro 13
Testing effectiveness (Phase 2)Study completedNCT02400567
What this trial is testing

Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women

Who this might be right for
Neoadjuvant Operable Breast Cancer
UNICANCER 125
Early research (Phase 1)Study completedNCT00050167
What this trial is testing

Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 603
Testing effectiveness (Phase 2)WithdrawnNCT01814865
What this trial is testing

Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer

Who this might be right for
Post-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer
British Columbia Cancer Agency
Testing effectiveness (Phase 2)Looking for participantsNCT05664893
What this trial is testing

Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS)

Who this might be right for
HER2 Negative Breast Cancer Not Immediately Operated
Centre Antoine Lacassagne 85
Not applicableUnknownNCT01850628
What this trial is testing

NSABP Biospecimen Discovery Project

Who this might be right for
Breast Cancer
NSABP Foundation Inc 50
Not applicableLooking for participantsNCT04281641
What this trial is testing

Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Fudan University 94
Not applicableUnknownNCT01592825
What this trial is testing

PiA: Prognosis Used Every Day for Patients With Operable Breast Cancer - Comparison of Invasion Factors uPA/PAI-1 With Other Prognostic Factors

Who this might be right for
Breast Cancer
Martin-Luther-Universität Halle-Wittenberg 1,000
Not applicableUnknownNCT00502684
What this trial is testing

Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery

Who this might be right for
Primary Operable Breast Cancer
Kaplan Medical Center 32
Testing effectiveness (Phase 2)Study completedNCT00301548
What this trial is testing

Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsCarcinoma
European Institute of Oncology 172
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation